Variant report
Variant | esv3449810 |
---|---|
Chromosome Location | chr8:62174500-62174902 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374094060 | chr8:62174534-62174535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs71559329 | chr8:62174535-62174536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576239865 | chr8:62174551-62174552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs71899452 | chr8:62174552-62174553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140249059 | chr8:62174553-62174554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200948008 | chr8:62174556-62174557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370310372 | chr8:62174557-62174558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28463260 | chr8:62174559-62174560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61199042 | chr8:62174569-62174570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71257359 | chr8:62174579-62174580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57278209 | chr8:62174581-62174582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578083853 | chr8:62174600-62174601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192415367 | chr8:62174627-62174628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548025018 | chr8:62174646-62174647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139061927 | chr8:62174679-62174680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527996530 | chr8:62174715-62174716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2919315 | chr8:62174729-62174730 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs182636798 | chr8:62174730-62174731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536478724 | chr8:62174751-62174752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35418604 | chr8:62174840-62174841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370574882 | chr8:62174861-62174862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7844667 | chr8:62174880-62174881 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs550265228 | chr8:62174881-62174882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2978491 | chr8:62174901-62174902 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:62170800-62176200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr8:62172000-62175200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr8:62172200-62174600 | Enhancers | Fetal Intestine Small | intestine |
4 | chr8:62172400-62175200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr8:62172600-62175200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr8:62172600-62175200 | Weak transcription | GM12878-XiMat | blood |
7 | chr8:62172800-62175200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr8:62172800-62176200 | Weak transcription | H9 Cell Line | embryonic stem cell |
9 | chr8:62173200-62174600 | Enhancers | Adipose Nuclei | Adipose |
10 | chr8:62174000-62174800 | Enhancers | Duodenum Mucosa | Duodenum |
11 | chr8:62174200-62175600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr8:62174600-62177400 | Weak transcription | Adipose Nuclei | Adipose |